Malleability of Human Aging : The Curious Case of Old-Age Mortality in Japan by Engelaer, Frouke M.
© 2013 Springer Publishing Company
http://dx.doi.org/10.1891/0198-8794.33.49
CHAPTER 3
Malleability of Human Aging
The Curious Case of Old-Age Mortality  
in Japan
Frouke M. Engelaer, Eugene M. G. Milne, David van Bodegom, 
Yasuhiko Saito, Rudi G. J. Westendorp, and Thomas B. L. Kirkwood
ABSTRACT
Steady growth in human life expectancy has been a key feature of the last 
century, with projected further increases likely to have enormous impacts 
on  societies worldwide. Despite the significance of these changes, our 
 understanding of the factors shaping this trend is incomplete. During most 
of the historical increase, by far, the major influence was progressive decline 
in early and midlife death rates because of the reduction in premature deaths, 
caused chiefly by infection. Recent decades have seen the emergence of a 
new driver of  increasing  longevity—declining mortality among those who 
are old already, pointing to greater malleability in human aging than had 
been foreseen. There is still debate, however, as to how much of this decrease 
in old age mortality is caused by a better early-life environment and how 
much is caused by improved conditions in late life. A unique resource exists 
in the case of Japan, where material circumstances for the general popula-
tion were consistently adverse through the early decades of the 20th cen-
tury but improved rapidly after 1950. Here, we compare the Japanese birth 
cohorts of 1900, 1910, and 1920 and follow their period and cohort mortal-
ity trends. The results show that cohorts with similar environments early in 
life have very different mortality trajectories in old age. This strengthens the 
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expectation that preventive measures in later life can deliver great benefit, 
while not contradicting the importance of life course approaches, to improv-
ing health and well-being.
INTRODUCTION
Over the last century, mortality in developed countries has decreased at all ages 
(Christensen, Doblhammer, Rau, & Vaupel, 2009; Oeppen & Vaupel, 2002; 
Vaupel, 2010). Initially, the largest decrease was in child mortality, and only 
in recent decades has the decrease been predominantly at old age (Kannisto, 
Lauritsen, Thatcher, & Vaupel, 1994; Vaupel, 1997). The determinants of the 
decrease in child mortality are well known and include improved hygiene, 
vaccinations, and other preventive measures. Exposures to infectious diseases 
and to poor nutrition early in life, including the period in utero, have been 
linked with mortality in old age (Barker, 2004, 2007; Bateson et al., 2004; 
Bengtsson & Lindstrom, 2003; Blackwell, Hayward, & Crimmins, 2001; Sayer 
et al., 1998). In the unusual case of individuals who were prenatally exposed to 
famine during the Dutch Hunger Winter in 1944–1945—when, for about six 
months, average daily adult intake was reduced to around 700 kcal— persistent 
epigenetic differences have been detected six decades later (Heijmans et al., 
2008). Individuals exposed periconceptionally to famine displayed, in their 
60s, significantly less DNA methylation of the imprinted IGF2 gene that is 
involved in human growth and development. In this accident of history, the 
timing of the nutritional stress could be determined with precision, and it is 
striking that individuals similarly exposed to famine, but during late gesta-
tion, did not show persistent epigenetic differences. Although the evidence that 
developmental and early life events can influence long-term health in rodents 
and humans is incontrovertible (Gluckman & Hanson, 2004; Gluckman, 
Hanson, & Beedle, 2007; Tarry-Adkins, Chen, Jones, Smith, & Ozanne, 2010; 
Tarry-Adkins, Martin-Gronert, Chen, Cripps, & Ozanne, 2008), much remains 
to be learned about the extent and scale of such effects within the broader con-
text of increasing human life expectancy. Furthermore, intervention strategies 
based solely on targeting developmental factors are of little use to the growing 
numbers of older adults.
Establishing the contribution of factors acting directly on mortality in later 
life is challenging. In most countries, improvements in living conditions have 
occurred relatively smoothly over time, so that the cohorts now reaching old age 
will have benefited from changes that have occurred throughout the life course. 
There are, however, instances where changes have been more  sudden. A study 
of changes in old-age mortality in East Germany after reunification with West 
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Germany has shown rapid convergence of death rates in the two populations—
rates in the East falling within little more than two decades to match those in the 
West (Scholz & Maier, 2003; Vaupel, Carey, & Christensen, 2003). However, this 
was only seen at very high age, when mortality rates always converge, and there 
are still some who argue that old-age mortality is biologically fixed (e.g., Carnes 
& Olshansky, 2007; Carnes, Olshansky, & Hayflick, 2012; Hayflick, 2000). Data 
from smoking cessation in old age does suggest, however, that health benefits 
can still be achieved even when the antismoking intervention was introduced in 
old age (Vetter & Ford, 1990).
A striking instance of transition to a long-living population structure is seen 
in Japan, which in recent years has led the world in life expectancy. Although 
many countries that experienced development through the 20th  century have 
witnessed some features of the same transition, the case of Japan is exceptional 
because of the relative uniformity of living conditions for the  general popula-
tion during the first half of the 20th century, as evidenced by mortality statistics, 
 followed by the rapid pace of improvements after 1950. Aspects of Japanese lon-
gevity are notably different from that in other countries, specifically the relatively 
small range of socioeconomic differences and the greater prominence of stroke 
as compared to heart disease (Ikeda et al., 2011). Nevertheless, Japan provides 
an intriguing “natural experiment” to examine impacts of health improvements 
at different stages in the life course, which can reasonably be expected to have 
general relevance for the broader biology of human aging and longevity.
METHODS
We used Japanese period and cohort mortality data for this study. Period mor-
tality data and cause-specific mortality data were retrieved from the publicly 
available Historical Statistics of Japan of the Japanese Ministry of Health, Labour 
and Welfare. Period mortality data were accessible for the years 1899–1903, 
1909–1913, and 1921–1925, with a 1 3 5 age-year interval. We employed these 
mortality data as an approximation to 1900, 1910, and 1920 period mortality 
data. We recognized issues on these official mortality data and studies revising 
these mortality data, notably by Mizushima (1962). However, the patterns of 
revised age-specific mortality rates were not significantly different from the offi-
cial mortality data when the three periods were compared. The cohort mortality 
data were obtained from a study conducted by Nanjo and Yoshinaga (2003) and 
were available with a 1 3 1 age-year interval.
All calculations were performed on publicly available population data. No 
participants were recruited for this study. Ethical approval was therefore not con-
sidered necessary to study population mortality and morbidity statistics.
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RESULTS
Figure 3.1 shows age-specific period and cohort mortality rates for the Japanese 
birth cohorts of 1900, 1910, and 1920 using publicly available data from the 
Historical Studies of Japan (Japan, 2011). Looking at period  mortality, the pro-
files in 1900, 1910, and 1920 were almost identical for all age categories.
We can thus use these data to compare period and cohort mortality rates of 
three populations that were similarly exposed to an adverse environment early in 
life and which began to experience a rapidly improving environment at age 30, 
40, and 50 years, respectively. These three birth cohorts had similar  mortality 
rates at younger ages; only around the age of 10 years, the mortality in 1910 
and 1920 was lower compared to 1900. The trends started to follow complete 
separate trajectories at middle age as conditions improved, and these differences 
persisted into old age. On closer observation, the 1920 birth cohort showed a 
mortality peak around the age of 25 years because of World War II, followed by a 
subsequent decrease of mortality before a steady increase with age. The 1910 and 
1900 birth cohorts showed similar patterns, with war-related mortality peaks 
around ages 35 and 45 years, respectively.
To study further the mortality differences at middle and old age as found 
in the cohort mortality data, we plotted the differences in cohort mortality 
rates of the 1910 and 1920 cohorts compared to the mortality rates of the 
1900 cohort, as shown in Figure 3.2. With the exception of infant mortality 
(age 0), the mortality rates of the 1910 and 1920 birth cohorts were very 
similar to the mortality rates of the 1900 cohort at younger ages for both 
females and males. However, from 1950 onward, with the improvement of 
the environment after the war, the mortality rates were considerably lower for 
the more recent birth cohorts. For the 1910 cohort, the mortality difference 
started at age 40 years and persisted up to old age. The 1920 birth cohort 
started to diverge at age 30 years and shows the strongest mortality decrease 
at old age.
In addition to the all-cause mortality data, it is important to consider 
changes in causes of death. Table 3.1 presents the cause-specific death rates of the 
age group 65–75 years for the periods 1965–1974, 1975–1984, and 1985–1994, 
respectively, corresponding to the cohorts born in 1900, 1910, and 1920. For 
individuals born in 1920, most cause-specific death rates (cerebrovascular dis-
ease, heart disease, tuberculosis, peptic ulcer, accidents, and suicides) were lower 
than in the 1900 birth cohort. The reduction in mortality was most pronounced 
for deaths caused by cerebrovascular disease. Only the mortality rates caused by 
smoking-related malignancies (trachea, bronchus, and lung) were higher for the 
1920 cohort. Nevertheless, the overall mortality of malignancies was lower for 
the 1920 birth cohort.
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FIGURE 3.2 Cohort mortality rate differences of the 1910 and 1920 birth cohorts when 
compared to the 1900 birth cohort for (a) females and (b) males.
DISCUSSION
Our analysis of these Japanese data reveals that cohorts with similar environmen-
tal conditions early in life had very different old-age mortality trajectories when 
exposed to environmental improvements at middle age. Mortality of the 1920 
cohort was significantly lower compared to the cohorts from 1900 and 1910. 
This difference was mainly because of large reductions in cerebrovascular disease, 
which was the major cause of death in Japan. These findings strongly suggest 
that a large part of the mortality benefit is through old-age plasticity supporting 
growing recognition of the malleability of human aging (Kirkwood, 2008). The 
contrary view—that old-age mortality is essentially fixed—is still held, however, 
and underlies, for example, the concept of “compression of morbidity,” which 
suggests that the goal of age-related medicine should be to postpone as far as 
possible the onset of diseases within the fixed human lifespan (Fries, 2002), at 
least until such time as science can slow down the aging process itself (Carnes 
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Causes of Death 1900 Cohort 1910 Cohort 1920 Cohort
Cerebrovascular disease 1,142 610 277
Heart diseasea  464 411 314
Malignant neoplasm  744 719 688
Smoking relatedb   86 152 141
All other  658 567 547
Tuberculosis   86  33  11
Peptic ulcer   47  21   8
Accidents   84  59  58
Suicides   44  39  29
Mortality rates are per 100,000 per year, including hypertension,a trachea,b bronchus, and lung. Table 3.1 
is generated from cause-specific mortality rates for the birth cohorts born in 1900, 1910, and 1920 at the 
age of 65–75 years. Consequently, it consists of period mortality data from 1965 to 1974, 1975 to 1984, 
and 1985 to 1994 for the 1900, 1910, and 1920 cohorts, respectively. The cause-specific death rates 
were calculated per 100,000 persons per year by dividing the total number of deaths caused by a specific 
cause, by the population size of that age group in that year, and then multiplied by 100,000.
TABLE 3.1
Cause-Specific Mortality Rates at Age 65–75 Years
& Olshansky, 2007; Carnes et al., 2012; Le Bourg, 2012; Olshansky, Carnes, & 
Cassel, 1990; Olshansky, Carnes, & Desesquelles, 2001).
In view of the scale of the societal impacts of increasing human life expec-
tancy, it remains important to establish the mechanisms that underlie the  ongoing 
declines in death rates at the oldest ages, which, in general, show associations 
both at international level with wealth as measured by gross domestic product 
(Janssen, Kunst, & Mackenbach, 2006) and intranationally with socioeconomic 
status (Jakab & Marmot, 2012). In Japan, it is clear that socioeconomic conditions 
improved rapidly after 1950, but the “proximate” causes that mediate between 
wealth and health in reducing mortality are less clear. One possibility is simply 
that better medical care interventions became available, as in the example of 
cardiovascular disease management (Ford et al., 2007). Improvements in health 
care could explain the observed reduction in cerebrovascular disease, which has 
been suggested by others as well (Ikeda et al., 2011). The potential importance 
of medical care to falling mortality is, however, commonly overstated (Olshansky 
et al., 2005). In addition, in the case of Japan, a significant step in reducing social 
inequalities was the introduction of the universal coverage of health insurance 
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in 1961 (Fukawa, 2002). It can be argued that more universal access to existing 
medical care and preventive interventions may have played a part.
An alternative possibility is that improved living conditions act  systematically 
on the array of factors that either exacerbate or improve the progressive accumula-
tion of various forms of damage. That is, the improvement might arise not because 
diseases are treated better or more universally but because diseases themselves prog-
ress more slowly or are ameliorated by improved general conditions. For example, 
many deaths attributed to heart disease and stroke can be identified as proximate 
consequences of cold exposure in winter (Eurowinter Group, 1997). Amelioration of 
cold exposures with improving social conditions may thus have an impact on many 
specific causes of death without any change in the classical risk factors or treatments 
of those specific causes. Older people also suffer extensive comorbidity—for exam-
ple, in one detailed study of a 1921 birth cohort of 85-year-olds in Newcastle upon 
Tyne, most participants had between four and six age-related diseases (Collerton et 
al., 2009). It would not be at all surprising to see environmental and social improve-
ments impacting upon  several or all such comorbidities simultaneously.
Finally, it is possible that a general improvement in environment,  living 
conditions, and social well-being might impact upon the accumulation of 
 molecular and cellular damage that is thought to constitute the intrinsic aging 
process (Kirkwood, 2005). That is, aging itself might be slowed from different 
ages in the different cohorts considered. Such an explanation, which involves the 
diverse effects of nutrition, lifestyle, occupation, and so forth, interacting with 
biochemical stresses and repair mechanisms could be compatible with the strong 
socioeconomic gradients seen in health and life expectancy. However, although 
not undisputed (Koopman et al., 2011; Rozing & Westendorp, 2008), it is con-
sidered that the slope of log mortality rates is an indicator of the population rate 
of aging (Finch, 1990), and it should be noted that the progressive reductions of 
risk between the cohorts reported here bring about either a parallel reduction or 
a small increase in the gradient of the log-mortality slope.
In conclusion, cohorts with similar early life environments have very dif-
ferent mortality trajectories in old age, indicating that old age mortality is much 
more malleable than commonly thought. This strengthens the expectation that 
interventions in later life, which include lifestyle (especially exercise), nutrition, 
and proactive health screening with preventive medical treatments such as sta-
tins and control of moderate hypertension, can deliver great benefit.
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